SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-037362
Filing Date
2020-11-16
Accepted
2020-11-16 16:11:28
Documents
10
Effectiveness Date
2020-11-16

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea129988-defa14a_chinapharma.htm DEFA14A 61456
2 GRAPHIC image_001.jpg GRAPHIC 2375
3 GRAPHIC image_002.jpg GRAPHIC 1835
4 GRAPHIC image_003.jpg GRAPHIC 1654
5 GRAPHIC image_004.jpg GRAPHIC 1999
6 GRAPHIC image_005.jpg GRAPHIC 2194
7 GRAPHIC image_006.jpg GRAPHIC 1732
8 GRAPHIC image_007.jpg GRAPHIC 1563
9 GRAPHIC image_008.jpg GRAPHIC 2285
10 GRAPHIC image_009.jpg GRAPHIC 9024
  Complete submission text file 0001213900-20-037362.txt   98018
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34471 | Film No.: 201316949
SIC: 2834 Pharmaceutical Preparations